Gelatin- zirconium based metal-organic framework (MOF 801) nanocomposite scaffold for bone tissue engineering

Abstract

Tissue engineering applications in bone defect treatment have shown promising outcomes over the past decade. In this context, taking advantage of bioactive scaffolds mimicking the intrinsic composition of bone has resulted in remarkable effects on bone regeneration. In this study, Zirconium-based metal-organic framework, known as MOF 801, was synthesized and incorporated into the gelatin matrix as an osteoconductive agent to fabricate a nanocomposite bone scaffold by freeze-drying method. Physical and chemical characteristics of MOF 801 and nanocomposite scaffolds were analyzed using FE-SEM, EDS, XRD, ICP and FTIR. Besides, the biological activity of the prepared scaffolds was evaluated by MTT, alizarin red staining, crystal violet staining, and ALP assays. Inclusion of MOF 801 NPs into the scaffolds resulted in enhancement of their compressive strength up to 15 ± 0.05 MPa. The nanocomposite samples containing MOF 801 NPs also exhibited favorable bioactive feature that was confirmed by their apatite-forming ability on their surfaces upon immersion in SBF solution. The Zr ion and fumarate release studies illustrated sustained release profiles from the gelatin matrix, leading to both antioxidant and anti-inflammatory properties. MTT assay results affirmed biocompatibility of scaffolds containing up to 5 % w/w MOF 801, besides the crystal violet assay exhibited proper cell confluency and adhesion. Eventually, Alizarin red and ALP activity assays revealed that an increment of MOF 801 could induce calcium mineralization and Alkaline Phosphatase enzyme production in MG-63 cells confirming the potential of prepared scaffolds for related bone tissue engineering applications.